B3GNT6

Chr 11

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6

Also known as: B3Gn-T6, BGnT-6, beta-1, 3-Gn-T6, beta3Gn-T6

The protein encoded by this gene is a beta-1,3-N-acetylglucosaminyltransferase that adds an N-acetylglucosamine moiety to N-acetylgalactosamine-modified serine or threonine. The encoded enzyme is responsible for creating the core 3 structure of O-glycans, which are important components of mucin-type glycoproteins. [provided by RefSeq, Dec 2016]

OMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

UniProtMuscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A13
0
Active trials
9
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.89
LOEUF
GOF
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.89LOEUF
pLI 0.000
Z-score -0.93
OE 1.34 (0.84–1.89)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.22Z-score
OE missense 1.04 (0.94–1.16)
247 obs / 237.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.34 (0.84–1.89)
0≤0.351.4
Missense OE?1.04 (0.94–1.16)
0≤0.61.4
Synonymous OE?0.95
0≤1.21.6
LoF obs/exp: 12 / 9.0Missense obs/exp: 247 / 237.6Syn Z: 0.40

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

B3GNT6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →